Healthcare / Biotechnology & Medical ResearchUpdated 2026-05-10 22:07 UTC

WSE/SCS stock hub

WSE/SCS has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

WSE/SCSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

16.9M

Warsaw Stock Exchange

Market data

Price

Recent price action with selectable time range.

WSE/SCSWSE/SCS

—

Loading chart…

In the news

Latest news · WSE/SCS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC-7.5

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All WSE/SCS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

169

Groups with data

Currency

PLN

Showing 169 of 169 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Poland
Country code	PL
Employees	0.75
Employees Change	0%
Employees Change Percent	0
Enterprise value	PLN 17.1M
Exchange	Warsaw Stock Exchange
Financial currency	PLN
First seen	2026-05-10
Industry	Biotechnology & Medical Research
Last refreshed	2026-05-10
Market cap	PLN 16.9M
Price	PLN 0.41
Price currency	PLN
Rev Per Employee	115,736x
Sector	Healthcare
Sic	2836
Symbol	wse/SCS
Website	https://stemcellsspin.com.pl

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-3.01%
EV Earnings	-33.49x
EV/EBITDA	13.07x
EV/FCF	-384.89x
EV/Sales	147.85x
FCF yield	-0.26%
P/B ratio	2.59x
P/S ratio	146.44x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBITDA Margin	1,131.03%
Gross margin	91.06%
Gross Profit	PLN 105,391
Gross Profit Growth	-14.48%
Gross Profit Growth3 Y	7.63%
Gross Profit Growth5 Y	-14.02%
Net Income	PLN -510,920
Pretax Margin	-441.45%
Profit Per Employee	PLN -510,920
Roa5y	-0.85
ROCE	-5.15
Roe5y	-2.11
ROIC	-7.51
Roic5y	-2.43

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-12.34%
Cagr1y	141.32%
Cagr3y	2.75%
Cagr5y	-19.86%
OCF Growth10 Y	-11%
OCF Growth5 Y	255.13%
Revenue Growth	-30.59x
Revenue Growth3 Y	-0.69x
Revenue Growth5 Y	-17.36x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	PLN 9.9M
Cash	PLN 12,348
Current Assets	PLN 707,086
Current Liabilities	PLN 99,593
Debt	PLN 175,704
Debt EBITDA	PLN 0.13
Debt Equity	PLN 0.03
Debt FCF	PLN -3.95
Equity	PLN 6.5M
Interest Coverage	-133.7
Liabilities	PLN 3.4M
Long Term Assets	PLN 9.2M
Long Term Liabilities	PLN 3.3M
Net Cash	PLN -163,356
Net Cash By Market Cap	PLN -0.96
Net Debt EBITDA	PLN 0.12
Net Debt Equity	PLN 0.03
Tangible Book Value	PLN 6.5M
Tangible Book Value Per Share	PLN 0.16
WACC	6.58

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	7.1
Net Working Capital	PLN 655,145
Quick ratio	0.67
Working Capital	PLN 607,493

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-73.2%
1Y total return	141.18%
200-day SMA	0.39
3Y total return	8.47%
50-day SMA	0.39
50-day SMA vs 200-day SMA	50over200
5Y total return	-66.94%
All Time High	4.05
All Time High Change	-89.88%
All Time High Date	2012-01-17
All Time Low	0.14
All Time Low Change	192.86%
All Time Low Date	2025-04-11
ATR	0.03
Beta	0.43
Beta1y	-0.5
Beta2y	-0.18
Ch YTD	0.99
High	0.47
High52	0.52
High52 Date	2025-10-07
High52ch	-20.39%
Low	0.4
Low52	0.14
Low52 Date	2025-05-08
Low52ch	184.72%
Ma50ch	5.67%
Price vs 200-day SMA	5.92%
RSI	51.57
RSI Monthly	55.01
RSI Weekly	53.89
Sharpe ratio	1.21x
Sortino ratio	2.4
Tr YTD	0.99
Tr1m	13.89%
Tr1w	2.5%
Tr3m	2.5%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	PLN -506,569
Operating margin	-437.7

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,902,055%
Net Borrowing	56,400
Shares Insiders	5.72%
Shares Out	41,336,500
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	PLN -44,458
Average Volume	7,979.05x
Bv Per Share	0.16
CAPEX	PLN -3.3M
Ch10y	-73.2
Ch1m	13.89
Ch1w	2.5
Ch1y	141.2
Ch3m	2.5
Ch3y	8.47
Ch5y	-66.94
Ch6m	4.59
Change	-8.89%
Change From Open	1.99
Close	0.45
Days Gap	-10.67
Depreciation Amortization	1,815,573
Dollar Volume	2,136.5
Earnings Date	2026-05-15
EBIT	PLN -506,569
EBITDA	PLN 1.3M
EPS	PLN -0.01
F Score	3
FCF	PLN -44,458
FCF EV Yield	-0.26x
FCF Per Share	PLN -0
Financing CF	56,400
Fiscal Year End	December
Founded	2,009
Investing CF	-3,288,063
Is Primary Listing	1
Last Earnings Date	2026-02-13
Last Report Date	2025-09-30
Ma150	0.4
Ma150ch	3.43%
Ma20	0.4
Ma20ch	2.58%
Net CF	11,941
Next Earnings Date	2026-05-15
Open	0.4
P OCF Ratio	5.23
Position In Range	12.12
Ppne	10,044
Price Date	2026-05-06
Price EBITDA	PLN 12.95
Ptbv Ratio	2.61
Relative Volume	0.65x
Revenue	115,736x
Tr6m	4.59%
Volume	5,211
Z Score	1.68

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does WSE/SCS pay a dividend?

Capital-return profile for this ticker.

Performance

WSE/SCS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns WSE/SCS?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+5.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

WSE/SCS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

51.6

Neutral momentum band

Price vs 200-day MA

+5.9%

50/200-day relationship not available

Beta (5Y)

0.43

Less volatile than the market

Sharpe ratio

1.21

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About WSE/SCS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current wse/SCS stock rating?

wse/SCS is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full wse/SCS analysis?

The full report lives at /stocks/wse/SCS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for wse/SCS?

The latest report frames wse/SCS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the wse/SCS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.